Literature DB >> 23334823

A complement a day keeps the Fox(p3) away.

Gaelle Le Friec, Jörg Köhl, Claudia Kemper.   

Abstract

Mesh:

Substances:

Year:  2013        PMID: 23334823     DOI: 10.1038/ni.2515

Source DB:  PubMed          Journal:  Nat Immunol        ISSN: 1529-2908            Impact factor:   25.606


× No keyword cloud information.
  12 in total

Review 1.  Complement: a key system for immune surveillance and homeostasis.

Authors:  Daniel Ricklin; George Hajishengallis; Kun Yang; John D Lambris
Journal:  Nat Immunol       Date:  2010-08-19       Impact factor: 25.606

2.  Donor deficiency of decay-accelerating factor accelerates murine T cell-mediated cardiac allograft rejection.

Authors:  Vasile Pavlov; Hugo Raedler; Shuguang Yuan; Staci Leisman; Wing-Hong Kwan; Peter N Lalli; M Edward Medof; Peter S Heeger
Journal:  J Immunol       Date:  2008-10-01       Impact factor: 5.422

3.  Local synthesis of C3 within the splenic lymphoid compartment can reconstitute the impaired immune response in C3-deficient mice.

Authors:  M B Fischer; M Ma; N C Hsu; M C Carroll
Journal:  J Immunol       Date:  1998-03-15       Impact factor: 5.422

4.  IFN-gamma and IL-17 production in experimental autoimmune encephalomyelitis depends on local APC-T cell complement production.

Authors:  Jinbo Liu; Feng Lin; Michael G Strainic; Fengqi An; Robert H Miller; Cengiz Z Altuntas; Peter S Heeger; Vincent K Tuohy; M Edward Medof
Journal:  J Immunol       Date:  2008-05-01       Impact factor: 5.422

5.  A regulatory role for the C5a anaphylatoxin in type 2 immunity in asthma.

Authors:  Jörg Köhl; Ralf Baelder; Ian P Lewkowich; Manoj K Pandey; Heiko Hawlisch; Lihua Wang; Jennifer Best; Nancy S Herman; Alyssa A Sproles; Jörg Zwirner; Jeffrey A Whitsett; Craig Gerard; Georgia Sfyroera; John D Lambris; Marsha Wills-Karp
Journal:  J Clin Invest       Date:  2006-03       Impact factor: 14.808

6.  The C5a receptor (C5aR) C5L2 is a modulator of C5aR-mediated signal transduction.

Authors:  Claire E Bamberg; Charles R Mackay; Hyun Lee; David Zahra; Jenny Jackson; Yun Si Lim; Peter L Whitfeld; Stewart Craig; Erin Corsini; Bao Lu; Craig Gerard; Norma P Gerard
Journal:  J Biol Chem       Date:  2009-12-31       Impact factor: 5.157

7.  Locally produced complement fragments C5a and C3a provide both costimulatory and survival signals to naive CD4+ T cells.

Authors:  Michael G Strainic; Jinbo Liu; Danping Huang; Fengqi An; Peter N Lalli; Nasima Muqim; Virginia S Shapiro; George R Dubyak; Peter S Heeger; M Edward Medof
Journal:  Immunity       Date:  2008-03-06       Impact factor: 31.745

8.  The complement inhibitory protein DAF (CD55) suppresses T cell immunity in vivo.

Authors:  Jianuo Liu; Takashi Miwa; Brendan Hilliard; Youhai Chen; John D Lambris; Andrew D Wells; Wen-Chao Song
Journal:  J Exp Med       Date:  2005-02-14       Impact factor: 14.307

9.  The CD46-Jagged1 interaction is critical for human TH1 immunity.

Authors:  Gaëlle Le Friec; Devon Sheppard; Pat Whiteman; Christian M Karsten; Salley Al-Tilib Shamoun; Adam Laing; Laurence Bugeon; Margaret J Dallman; Teresa Melchionna; Chandramouli Chillakuri; Richard A Smith; Christian Drouet; Lionel Couzi; Veronique Fremeaux-Bacchi; Jörg Köhl; Simon N Waddington; James M McDonnell; Alastair Baker; Penny A Handford; Susan M Lea; Claudia Kemper
Journal:  Nat Immunol       Date:  2012-10-21       Impact factor: 25.606

10.  Absence of signaling into CD4⁺ cells via C3aR and C5aR enables autoinductive TGF-β1 signaling and induction of Foxp3⁺ regulatory T cells.

Authors:  Michael G Strainic; Ethan M Shevach; Fengqi An; Feng Lin; M Edward Medof
Journal:  Nat Immunol       Date:  2012-12-23       Impact factor: 25.606

View more
  11 in total

1.  Complement factor C5 but not C3 contributes significantly to hydrosalpinx development in mice infected with Chlamydia muridarum.

Authors:  Zhangsheng Yang; Turner Conrad; Zhou Zhou; Jianlin Chen; Pavel Dutow; Andreas Klos; Guangming Zhong
Journal:  Infect Immun       Date:  2014-05-19       Impact factor: 3.441

2.  Targeting the Complement Alternative Pathway Permits Graft Versus Leukemia Activity while Preventing Graft Versus Host Disease.

Authors:  Hung Nguyen; Ali Alawieh; David Bastian; Sandeepkumar Kuril; Min Dai; Anusara Daenthanasanmak; Mengmeng Zhang; Supinya Iamsawat; Steven D Schutt; Yongxia Wu; M Mahdi Sleiman; Akshay Shetty; Carl Atkinson; Shaoli Sun; Juan Carlos Varela; Stephen Tomlinson; Xue-Zhong Yu
Journal:  Clin Cancer Res       Date:  2020-01-09       Impact factor: 12.531

Review 3.  Complement and the Regulation of T Cell Responses.

Authors:  Erin E West; Martin Kolev; Claudia Kemper
Journal:  Annu Rev Immunol       Date:  2018-04-26       Impact factor: 28.527

Review 4.  Complement modulation of T cell immune responses during homeostasis and disease.

Authors:  Elizabeth V Clarke; Andrea J Tenner
Journal:  J Leukoc Biol       Date:  2014-09-10       Impact factor: 4.962

Review 5.  Targeting complement-mediated immunoregulation for cancer immunotherapy.

Authors:  Martin Kolev; Maciej M Markiewski
Journal:  Semin Immunol       Date:  2018-02-15       Impact factor: 11.130

6.  Anaphylatoxins Activate Ca2+, Akt/PI3-Kinase, and FOXO1/FoxP3 in the Retinal Pigment Epithelium.

Authors:  Catharina Busch; Balasubramaniam Annamalai; Khava Abdusalamova; Nadine Reichhart; Christian Huber; Yuchen Lin; Emeraldo A H Jo; Peter F Zipfel; Christine Skerka; Gerhild Wildner; Maria Diedrichs-Möhring; Bärbel Rohrer; Olaf Strauß
Journal:  Front Immunol       Date:  2017-06-15       Impact factor: 7.561

7.  Characterization of a Subset of Patients With Rheumatoid Arthritis for Whom Current Management Strategies are Inadequate.

Authors:  Claire M Bradford; Thomas McDonnell; Divya Raj; George A Robinson; Andrew Cole; Shashank Ramakrishnan; Rosa González-Serrano; Jasper Mak; Yusuf Cem Eskiocak; David A Isenberg; Coziana Ciurtin; Elizabeth C Jury; Jessica J Manson
Journal:  ACR Open Rheumatol       Date:  2019-04-22

Review 8.  Intracellular complement - the complosome - in immune cell regulation.

Authors:  Giuseppina Arbore; Claudia Kemper; Martin Kolev
Journal:  Mol Immunol       Date:  2017-06-07       Impact factor: 4.407

9.  Complement C3a and C5a receptor blockade modulates regulatory T cell conversion in head and neck cancer.

Authors:  Thomas E Bickett; Laurel B Darragh; Michael William Knitz; Jacob Gadwa; Shilpa Bhatia; Miles Piper; Benjamin Van Court; Shiv Bhuvane; Diemmy Nguyen; Varuna Nangia; Emily K Kleczko; Raphael A Nemenoff; Sana D Karam
Journal:  J Immunother Cancer       Date:  2021-03       Impact factor: 13.751

Review 10.  Complement--tapping into new sites and effector systems.

Authors:  Martin Kolev; Gaelle Le Friec; Claudia Kemper
Journal:  Nat Rev Immunol       Date:  2014-11-14       Impact factor: 53.106

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.